Singapore, Nov. 7 -- Australian startup Lumonus, a leader in artificial intelligence (AI) powered radiation oncology workflow solutions, has announced the close of its A$25 million Series B financing round. The round was led byAviron Investment Management with continued participation from Oncology Ventures.

This funding highlights the strong clinical adoption of Lumonus AI, with leading health systems across the United States, Australia, and Europewho are already integrating the platform into routine clinical care. To date, the Lumonus AI platform has supported clinicians in consulting and prescribing over 280,000 cancer treatments and has automated the creation of over 75,000 cancer treatment plans, demonstrating its impact in streamlin...